Diagnosis and management of hereditary colon cancer

Gastroenterology Clinics of North America

Volumn 31, Issue 2, 2002, Pages 537-549

  Cruz Correa, Marcia ^a   Giardiello, Francis M ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLON POLYPOSIS; COLORECTAL TUMOR; GENETIC PREDISPOSITION; GENETICS; HUMAN; MASS SCREENING; METHODOLOGY; PRECANCER; REVIEW; ADENOMATOUS POLYP; COLON CANCER; COLON RESECTION; COLORECTAL CANCER; FAMILIAL CANCER; GENETIC SCREENING; HISTOLOGY;

ADENOMATOUS POLYPOSIS COLI; COLORECTAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MASS SCREENING; PRECANCEROUS CONDITIONS; HUMAN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC;

EID: 0036314751     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(02)00009-2     Document Type: Review

References (52)

1. Cancer statistics, 2000
2. Familial colorectal cancer: Diagnosis and management
3. Colorectal cancer: Molecules and populations
4. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis
5. Identification of FAP locus genes from chromosome 5q21
6. Hereditary benign and malignant lesions of the large bowel
7. Familial polyposis coli
8. Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage
9. The risk of upper gastrointestinal cancer in familial adenomatous polyposis
10. Desmoid tumors in familial adenomatous polyposis
11. The value of combined phenotypic markers in identifying inheritance of familial adenomatous polyposis
12. Dental anomalies in familial adenomatous polyposis coli
13. A clinicopathological study of the eyes in familial adenomatous polyposis with extracolonic manifestations (Gardner syndrome)
14. Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis
15. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis
16. The risk of hepatoblastoma in familial adenomatous polyposis
17. Analysis of masked mutations in familial adenomatous polyposis
18. The molecular basis of Turcot syndrome
19. Attenuated familial adenomatous polyposis (AFAP): A phenotypically and genotypically distinctive variant of FAP
20. Phenotypic expression in adenomatous polyposis families with mutation in the 5′ region of the adenomatous polyposis coli gene
21. Familial colorectal cancer in Askenazim due to a hypermutable tract in APC
22. APC gene: Database of germline and somatic mutations in human tumors and cell lines
23. Colorectal tumors
24. Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients
25. APC gene mutations and extraintestinal phenotype of familial adenomatous polyposis
26. Genotype-phenotype correlations in attenuated adenomatous polyposis coli
27. Pigmented ocular fundus lesions and APC mutations in familial adenomatous polyposis
28. American Gastroenterological Association technical review on hereditary colorectal cancer and genetic testing
29. American Gastroenterological Association medical position statement: Hereditary colorectal cancer and genetic testing
30. Phenotypic variablity of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation
31. Colorectal cancer screening and surveillance: Clinical guidelines, evidence, and rationale
32. Hepatoblastoma and APC gene mutation in familial adenomatous
33. Total colectomy and ileorectal anastomosis
34. Rectal cancer risk in older patients with familial adenomatous polyposis and an ileorectal anastomosis: A cause for concern
35. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
36. The effect of celecoxib, a cyclooxygenase-2 inhibitor in familial adenomatous polyposis
37. Long-term treatment with sulindac in familial adenomatous polyposis: A prospective cohort study
38. Primary chemoprevention of familial adenomatous polyposis: Stratification of clinical response to sulindac by mucosal prostanoid levels
39. Hereditary factors in two large midwestern kindreds
40. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: Meeting highlights and Bethesda guidelines
41. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer
42. Microsatellite instability in sporadic carcinomas of the proximal colon: Association with diploid DNA content, negative protein expression of p53, and distinct histomorphologic features
43. New criteria for hereditary non-polyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC (ICG-HNPCC)
44. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients
45. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease
46. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers
47. Association of tumor site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer
48. NCCN colorectal cancer screening practice guidelines
49. Genetic testing for cancer susceptibility